HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TTC8
tetratricopeptide repeat domain 8
Chromosome 14 Β· 14q31.3
NCBI Gene: 123016Ensembl: ENSG00000165533.19HGNC: HGNC:20087UniProt: A0A0C4DGH8
40PubMed Papers
22Diseases
0Drugs
76Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingmitochondrioncentrosomeestablishment of anatomical structure orientationBardet-Biedl syndromeretinitis pigmentosaRetinal dystrophyBardet-Biedl syndrome 1
✦AI Summary

TTC8 is a core structural component of the BBSome, an octameric ciliary transport complex essential for protein sorting to primary cilia 1. As a tetratricopeptide repeat domain protein, TTC8 functions in BBSome assembly and ciliary localization, where it facilitates Rab8-mediated vesicle docking and fusion at the ciliary base to promote ciliary membrane extension 1. TTC8 also regulates sonic hedgehog pathway signaling through coordinated control of smoothened (SMO) ciliary trafficking with LTZL1. Loss-of-function TTC8 mutations cause two distinct disease phenotypes: Bardet-Biedl syndrome (BBS8), a multisystemic ciliopathy affecting kidney, retinal, reproductive, and olfactory systems 2, and nonsyndromic retinitis pigmentosa 51 (RP51), characterized by isolated retinal degeneration 3. Functionally, TTC8 represents a peripheral BBSome subunit with less critical roles in kidney development compared to core subunits, explaining variable clinical severity 1. The gene exhibits complex alternative isoform regulation in sensory tissues including the retina and pineal gland, with neural regulation of specific splice variants 4. Genome-wide association studies implicate the TTC8-containing chr14 locus in atherosclerotic phenotypes, suggesting broader vascular relevance 5. TTC8 mutations account for approximately 2.8% of BBS cases, establishing it as a minor but confirmed contributor to ciliopathic disease burden 6.

Sources cited
1
TTC8 is a peripheral BBSome subunit less critical for kidney function than core subunits; BBSome functions in ciliary protein trafficking
PMID: 31283077
2
TTC8 deletion causes syndromic Bardet-Biedl syndrome phenotype in dogs with retinal, renal, reproductive, and olfactory defects
PMID: 32962042
3
TTC8 mutations confirmed as causative for nonsyndromic retinitis pigmentosa 51 (RP51)
PMID: 26195043
4
TTC8 exhibits complex alternative isoform regulation in pineal gland and other neural tissues with neural regulation of splice variants
PMID: 27684375
5
TTC8-containing locus associated with carotid intima-media thickness and atherosclerotic events
PMID: 31406157
6
TTC8 (BBS8) mutations account for approximately 2.8% of Bardet-Biedl syndrome families
PMID: 19402160
Disease Associationsβ“˜22
Bardet-Biedl syndromeOpen Targets
0.81Strong
retinitis pigmentosaOpen Targets
0.77Strong
Retinal dystrophyOpen Targets
0.51Moderate
Bardet-Biedl syndrome 1Open Targets
0.50Moderate
polydactylyOpen Targets
0.46Moderate
genetic disorderOpen Targets
0.41Moderate
obesityOpen Targets
0.38Weak
eye diseaseOpen Targets
0.37Weak
Posterior column ataxia - retinitis pigmentosaOpen Targets
0.37Weak
Moderate intellectual disabilityOpen Targets
0.27Weak
Postaxial foot polydactylyOpen Targets
0.27Weak
Truncal obesityOpen Targets
0.27Weak
Macular dystrophyOpen Targets
0.26Weak
smoking initiationOpen Targets
0.26Weak
neurodegenerative diseaseOpen Targets
0.25Weak
diabetes mellitusOpen Targets
0.20Weak
glomerulonephritisOpen Targets
0.18Weak
type 2 diabetes mellitusOpen Targets
0.18Weak
Abruptio PlacentaeOpen Targets
0.17Weak
refractive errorOpen Targets
0.12Weak
Bardet-Biedl syndrome 8UniProt
Retinitis pigmentosa 51UniProt
Pathogenic Variants76
NM_144596.4(TTC8):c.600dup (p.His201fs)Pathogenic
Retinitis pigmentosa 51|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 201
NM_144596.4(TTC8):c.265+1G>APathogenic
Retinitis pigmentosa 51;Bardet-Biedl syndrome 8|Bardet-Biedl syndrome|Retinal dystrophy|not provided
β˜…β˜…β˜†β˜†2026
NM_144596.4(TTC8):c.677G>A (p.Trp226Ter)Pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 51|Retinal dystrophy
β˜…β˜…β˜†β˜†2025β†’ Residue 226
NM_144596.4(TTC8):c.69del (p.Cys23fs)Pathogenic
Bardet-Biedl syndrome 8|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 23
NM_144596.4(TTC8):c.739C>T (p.Gln247Ter)Pathogenic
Retinitis pigmentosa 51|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 247
NM_144596.4(TTC8):c.489G>A (p.Thr163=)Pathogenic
Bardet-Biedl syndrome 8|Bardet-Biedl syndrome|Postaxial foot polydactyly;Truncal obesity;Moderate intellectual disability|Retinal dystrophy|Retinitis pigmentosa 51|TTC8-related disorder|Ovarian serous cystadenocarcinoma|Bardet-Biedl syndrome 8;Retinitis pigmentosa 51|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 163
NM_144596.4(TTC8):c.624+1_624+2delLikely pathogenic
Retinitis pigmentosa 51|TTC8-related disorder|Retinitis pigmentosa 51;Bardet-Biedl syndrome 8|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2024
NM_144596.4(TTC8):c.799-2A>GLikely pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 51
β˜…β˜…β˜†β˜†2024
NM_144596.4(TTC8):c.256C>T (p.Gln86Ter)Pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 51
β˜…β˜…β˜†β˜†2024β†’ Residue 86
NM_144596.4(TTC8):c.915del (p.Met305fs)Pathogenic
Retinitis pigmentosa 51|Bardet-Biedl syndrome|TTC8-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 305
NM_144596.4(TTC8):c.293del (p.Gly98fs)Pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 51|Retinitis pigmentosa 51;Bardet-Biedl syndrome 8
β˜…β˜…β˜†β˜†2024β†’ Residue 98
NM_144596.4(TTC8):c.559C>T (p.Gln187Ter)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 8|Retinitis pigmentosa 51
β˜…β˜…β˜†β˜†2023β†’ Residue 187
NM_144596.4(TTC8):c.936del (p.Glu313fs)Pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 51
β˜…β˜…β˜†β˜†2023β†’ Residue 313
NM_144596.4(TTC8):c.901_905del (p.Arg300_Ile301insTer)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 8
β˜…β˜…β˜†β˜†2022β†’ Residue 300
NM_144596.4(TTC8):c.114+2T>CPathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 8
β˜…β˜…β˜†β˜†2022
NM_144596.4(TTC8):c.1049+2_1049+4delPathogenic
Bardet-Biedl syndrome 8|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2017
NM_144596.4(TTC8):c.327dup (p.Arg110Ter)Pathogenic
Bardet-Biedl syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 110
NM_144596.4(TTC8):c.153G>A (p.Trp51Ter)Pathogenic
Bardet-Biedl syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 51
NM_144596.4(TTC8):c.826_829dup (p.Ala277fs)Pathogenic
Retinal dystrophy|Bardet-Biedl syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 277
NM_144596.4(TTC8):c.910-1G>ALikely pathogenic
Bardet-Biedl syndrome
β˜…β˜†β˜†β˜†2025
View on ClinVar β†—
Related Genes
MCHR1Protein interaction100%SSTR3Protein interaction100%TRIM32Protein interaction100%WDPCPProtein interaction100%LZTFL1Protein interaction100%MKS1Protein interaction100%
Tissue Expression6 tissues
Ovary
100%
Bone Marrow
68%
Heart
26%
Liver
25%
Brain
17%
Lung
10%
Gene Interaction Network
Click a node to explore
TTC8MCHR1SSTR3TRIM32WDPCPLZTFL1MKS1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q86U25
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.80LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.61 [0.47–0.80]
RankingsWhere TTC8 stands among ~20K protein-coding genes
  • #10,258of 20,598
    Most Researched40
  • #974of 5,498
    Most Pathogenic Variants76 Β· top quartile
  • #6,659of 17,882
    Most Constrained (LOEUF)0.80
Genes detectedTTC8
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301537
1.00
2
PMID: 20301590
0.90
3
Deletion in the Bardet-Biedl Syndrome Gene
PMID: 32962042
Genes (Basel) Β· 2020
0.80
4
FAM161A and TTC8 are Differentially Expressed in Non-Allelelic Early Onset Retinal Degeneration.
PMID: 26427412
Adv Exp Med Biol Β· 2016
0.70
5
Confirmation of TTC8 as a disease gene for nonsyndromic autosomal recessive retinitis pigmentosa (RP51).
PMID: 26195043
Clin Genet Β· 2016
0.60